Company Overview and News

Top 5 Nickel Miners To Consider Before The Nickel Boom

2018-03-28 seekingalpha
Nickel is likely to do well in 2018 to 2020 as it recovers from a severe bear market.
Upvote Downvote

Director Declaration

2017-05-24 londonstockexchange
Dublin, London, 24 May 2017: Pursuant to paragraph 6.6.8(2) of the ISE Listing Rules and LR 9.6.14R(2) of the FCA Listing Rules, Smurfit Kappa Group plc notifies the following in relation to Ms. Christel Bories, who is a director of the Company:-
Upvote Downvote

Argentina Eyeing Lithium Superpower Status Amid Battery Boom

2017-03-08 renewableenergyworld
Last week to submit an abstract to speak at the world’s largest gathering of power professionals. Click here to submit your abstract for POWER-GEN now.
Upvote Downvote

Argentina's Lithium Superpower Ambition Is Good News for Tesla - Bloomberg

2017-03-06 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

French Mining Company In Trouble - Bailout, Whatever It Takes

2016-09-29 seekingalpha
Eramet SA (OTC:ERMAF) is, after Vallourec (OTCPK:VLOUF) (see article here), an additional French company that looks kind of interesting. Of course, it is another distressed story with event-driven character that appears on my screen with non-negligible risks. Nevertheless, there are a few interesting points for ERMAF I would like to present.
Upvote Downvote

Mitsubishi Sees Three Years Needed for Shift From Commodities - Bloomberg

2016-08-28 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

Lithium Extraction Techniques - A Look At The Latest Technologies And The Companies Involved

2016-07-14 seekingalpha
When I talk about the lithium miners with industry experts and industry insiders, the most interesting and yet unknown area, involves that of the disruptive lithium extraction technologies.
Upvote Downvote

The Term Sheet | Newsletters

2016-04-25 fortune
On Friday I mentioned a Legg Mason survey about affluent investors and the "American Dream." Below are my thoughts on it, but I've also received dozens of emails that I plan to address (and likely publish) later this week. In short, many of you disagree with Legg Mason's threshold for affluence. Keep em coming...
Upvote Downvote

Deals of the day-Mergers and acquisitions

2016-04-25 reuters
April 25 The following bids, mergers, acquisitions and disposals were reported by 1000 GMT on Monday:
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...